1IRTC Stock Overview

A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. More details

1IRTC fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	4/6
Past Performance	0/6
Financial Health	2/6
Dividends	0/6

Rewards

Earnings are forecast to grow 70.9% per year

Risk Analysis

Shares are highly illiquid

Significant insider selling over the past 3 months

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

iRhythm Technologies, Inc. Competitors

DiaSorin

BIT:DIA

€5.3b

EL.En

BIT:ELN

€723.1m

Amplifon

BIT:AMP

€3.9b

I.M.D. International Medical Devices

BIT:IMD

€27.0m

Price History & Performance

Summary of share price highs, lows and changes for iRhythm Technologies
Historical stock prices
Current Share Price	US$113.00
52 Week High	US$0
52 Week Low	US$0
Beta	1.45
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	22.16%

Recent updates

Shareholder Returns

	1IRTC	IT Medical Equipment	IT Market
7D	n/a	0.6%	2.8%
1Y	n/a	2.7%	13.0%

Return vs Industry: Insufficient data to determine how 1IRTC performed against the Italian Medical Equipment industry.

Return vs Market: Insufficient data to determine how 1IRTC performed against the Italian Market.

Price Volatility

Is 1IRTC's price volatile compared to industry and market?
1IRTC volatility
1IRTC Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	5.6%
Market Average Movement	5.3%
10% most volatile stocks in IT Market	8.7%
10% least volatile stocks in IT Market	3.3%

Stable Share Price: 1IRTC's share price has been volatile over the past 3 months compared to the Italian market.

Volatility Over Time: Insufficient data to determine 1IRTC's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2006	2,000	Quentin Blackford	www.irhythmtech.com

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data.

iRhythm Technologies, Inc. Fundamentals Summary

How do iRhythm Technologies's earnings and revenue compare to its market cap?
1IRTC fundamental statistics
Market cap	€3.70b
Earnings (TTM)	-€86.97m
Revenue (TTM)	€547.14m

6.8x

P/S Ratio

-42.6x

P/E Ratio

Is 1IRTC overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1IRTC income statement (TTM)
Revenue	US$618.59m
Cost of Revenue	US$189.36m
Gross Profit	US$429.23m
Other Expenses	US$527.55m
Earnings	-US$98.32m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)	-3.08
Gross Margin	69.39%
Net Profit Margin	-15.89%
Debt/Equity Ratio	746.8%

How did 1IRTC perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/04 07:20
End of Day Share Price	2025/05/02 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

iRhythm Technologies, Inc. is covered by 22 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Michael Polark	Baird
David Rescott	Baird
Joanne Wuensch	BMO Capital Markets Equity Research

iRhythm Technologies BIT:1IRTC Stock Report